Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE

Neuroscience Letters

Volumn 265, Issue 2, 1999, Pages 147-150

  Soulié, Cathia ^a   Mitchell, Valérie ^a   Dupont Wallois, Lætitia ^a   Chartier Harlin, Marie Christine ^a   Beauvillain, Jean Claude ^a   Delacourte, André ^a   Caillet Boudin, Marie Laure ^a  

^a INSERM   (France)

Author keywords

Apolipoprotein E; Apolipoprotein E mRNA; In situ hybridization; NGF differentiation; SK N SH SY 5Y cells

Indexed keywords

APOLIPOPROTEIN E; MESSENGER RNA; NERVE GROWTH FACTOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; LIPOPROTEIN SYNTHESIS; MESSENGER RNA SYNTHESIS; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

APOLIPOPROTEINS E; CELL DIFFERENTIATION; HUMANS; ISOMERISM; NERVE GROWTH FACTORS; NEURONS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033574672     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00167-6     Document Type: Article

References (19)

1. Arai Y., Mizuguchi M., Ikeda K., Takashima S. Transient expression of apolipoprotein-E in neonates with pontosubicular neuron necrosis. Acta Neuropathol. 91:1996;396-399.
2. Corder E.H., Saunders A.M., Rish N.J., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Rimmler J.B., Locke P.A., Conneally P.M., Schmader K.E., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7:1994;180-183.
3. DeMattos R.B., Curtiss L.K., Williams D.L. A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins. J. Biol. Chem. 273:1998;4206-4212.
4. Diedrich J.F., Minnigan H., Carp R.I., Whitaker J.N., Race R., Frey W., Haase A.T. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin in astrocytes. J. Virol. 65:1991;4759-4768.
5. Dupont-Wallois L., Sautière P.E., Coquerelle C., Bailleul B., Delacourte A., Caillet-Boudin M.L. Shift from fetal-type to Alzheimer-type phosphorylated Tau proteins in SKNSH-SY 5Y cells treated with okadaic acid. FEBS Lett. 357:1995;197-201.
6. Dupont-Wallois L., Soulié C., Sergeant N., Wavrant-de-Wriez F., Chartier-Harlin M.C., Delacourte A., Caillet-Boudin M.L. ApoE synthesis in human neuroblastoma cells. Neurobiol. Dis. 4:1997;356-364.
7. Han S.H., Einstein G., Weisgraber K., Strittmatter W.J., Saunders A.M., Pericak-Vance M., Roses A., Schmechel D.E. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53:1994;535-544.
8. Ignatius M.J., Gebicke-Härter P.J., Skene J.H.P., Schilling J.W., Weisgraber K.H., Mahley R.W., Shooter F.M. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Natl. Acad. Sci. USA. 83:1986;1125-1129.
9. Marques M.A., Tolar M., Crutcher K.A. Apolipoprotein E exhibits isoform-specific neurotoxicity. Alzheimer's Res. 3:1997;1-6.
10. Masliah E., Mallory M., Ge N.F., Alford M., Veinbergs I., Roses A.D. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136:1995;107-122.
11. Metzger R.E., LaDu M.J., Pan J.B., Getz G.S., Frail D.E., Fadulto M.T. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;372-380.
12. Nathan B.P., Bellosta S., Sanan D.A., Weisgraber K.H., Mahley R.W., Pitas R.E. Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro. Science. 264:1994;850-852.
13. Pahlman S., Mamaeva S., Meyerson G., Mattson M.E.K., Bjelfman C., Ortoft E., Hammerling U. Human neuroblastoma cells in culture: a model for neuronal cell differentiation and function. Acta Physiol. Scand. 140:1990;25-37.
14. Poirier J., Hess M., May P.C., Finch C.E. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol. Brain Res. 11:1991;97-106.
15. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J. Apolipoprotein E: high-avidity binding to (-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
16. Weisgraber K.H., Rall S.C. Jr., Mahley R.W. Human E apolipoprotein heterogeneity. J. Biol. Chem. 256:1981;9077-9083.
17. Xu P.T., Schmechel D., Rothrock-Christian T., Buckart D.S., Qiu H.L., Popko B., Sullivan P., Maeda N., Saunders A.M., Roses A.D., Gilbert J.R. Human apolipoprotein E2,E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol. Dis. 3:1996;229-245.
18. Xu P.T., Gilbert J.R., Qiu H.L., Rothrock-Christian T., Settles D.L., Roses A.D., Schmechelk D.E. Regionally specific neuronal expression of human APOE gene in transgenic mice. Neurosci Lett. 246:1998;65-68.
19. Zarow C., Victoroff J. Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning. Exp. Neurol. 149:1998;79-86.